This shift is consistent with the observation that chemo- and immunoprevention strategies that target the stem cell compartment, including atorvastatin and a vaccine against Ascl2, are most effective when administered prior to tumor formation (4, 5). The gene discussed is ASCL2; the disease is neoplasm.